NCT04635280View on ClinicalTrials.gov

Evaluation of Satisfaction Regarding Home Healthcare Provider (HHP) Management of Type 1 Diabetic Patients Using a Closed-loop Automatic Insulin Delivery System

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions
Diabetes type1
Interventions
DEVICE

any closed-loop automatic insulin delivery system (or artificial pancreas) European Conformity (CE)-marking

A closed-loop automatic insulin delivery system includes a combination of an insulin pump, a continuous glucose monitoring system and an algorithm.

Trial Locations (2)

31059

CHU de Toulouse - Hôpital Rangueil, Toulouse

44093

CHU de Nantes - Hôpital Nord Laennec, Nantes

All Listed Sponsors
lead

Air Liquide Santé International

INDUSTRY